Stefan Bilz

Stefan Bilz

Auto-generated profile, based on publicly available information

Stefan Bilz

Klinik für Endokrinologie, Diabetologie, Osteologie und Stoffwechselerkrankungen, Kantonspital St. Gallen, St. Gallen, Switzerland

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2004 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
VSVarman T. Samuel
Varman T. Samuel
ZLZhen-Xiang Liu
Zhen-Xiang Liu
XQXianqin Qu
Xianqin Qu
BEBenjamin D. Elder
Benjamin D. Elder
SBStefan Bilz
Stefan Bilz
GSGerald I. Shulman
Gerald I. Shulman
Short term high fat feeding in rats results specifically in hepatic fat accumulation and provides a model of non-alcoholic fatty liver disease in which to study the mechanism of hepatic insulin resistance. Short term fat feeding (FF) caused a ∼3-fold increase in liver triglyceride and total fatty acyl-CoA content without any significant increase in visceral or skeletal muscle fat content. Suppression of endogenous glucose production (EGP) by insulin was diminished in the FF group, despite normal basal EGP and insulin-stimulated peripheral glucose disposal. Hepatic insulin resistance could be attributed to impaired insulin-stimulated IRS-1 and IRS-2 tyrosine phosphorylation. These changes were associated with activation of PKC-ϵ and JNK1. Ultimately, hepatic fat accumulation decreased insulin activation of glycogen synthase and increased gluconeogenesis. Treatment of the FF group with low dose 2,4-dinitrophenol to increase energy expenditure abrogated the development of fatty liver, hepatic insulin resistance, activation of PKC-ϵ and JNK1, and defects in insulin signaling. In conclusion, these data support the hypothesis hepatic steatosis leads to hepatic insulin resistance by stimulating gluconeogenesis and activating PKC-ϵ and JNK1, which may interfere with tyrosine phosphorylation of IRS-1 and IRS-2 and impair the ability of insulin to activate glycogen synthase.

1 April 2017 in The Lancet
Verified
Journal Article
Closed access
AAArne Astrup
Arne Astrup
KFKen Fujioka
Ken Fujioka
FGFrank Greenway
Frank Greenway
DLDavid C W Lau
David C W Lau
LGLuc Van Gaal
Luc Van Gaal
JSJames Alan Simon
James Alan Simon

1 December 2005 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
KMKatsutaro Morino
Katsutaro Morino
KPKitt Falk Petersen
Kitt Falk Petersen
SDSylvie Dufour
Sylvie Dufour
DBDouglas Befroy
Douglas Befroy
JFJared Frattini
Jared Frattini
GSGerald I. Shulman
Gerald I. Shulman
To further explore the nature of the mitochondrial dysfunction and insulin resistance that occur in the muscle of young, lean, normoglycemic, insulin-resistant offspring of parents with type 2 diabetes (IR offspring), we measured mitochondrial content by electron microscopy and insulin signaling in muscle biopsy samples obtained from these individuals before and during a hyperinsulinemic-euglycemic clamp. The rate of insulin-stimulated muscle glucose uptake was approximately 60% lower in the IR offspring than the control subjects and was associated with an approximately 60% increase in the intramyocellular lipid content as assessed by 1H magnetic resonance spectroscopy. Muscle mitochondrial density was 38% lower in the IR offspring. These changes were associated with a 50% increase in IRS-1 Ser312 and IRS-1 Ser636 phosphorylation and an approximately 60% reduction in insulin-stimulated Akt activation in the IR offspring. These data provide new insights into the earliest defects that may be responsible for the development of type 2 diabetes and support the hypothesis that reductions in mitochondrial content result in decreased mitochondrial function, which predisposes IR offspring to intramyocellular lipid accumulation, which in turn activates a serine kinase cascade that leads to defects in insulin signaling and action in muscle.

31 July 2007 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
KPKitt Falk Petersen
Kitt Falk Petersen
SDSylvie Dufour
Sylvie Dufour
DSDavid B. Savage
David B. Savage
SBStefan Bilz
Stefan Bilz
GSGina Solomon
Gina Solomon
GSGerald I. Shulman
Gerald I. Shulman
We examined the hypothesis that insulin resistance in skeletal muscle promotes the development of atherogenic dyslipidemia, associated with the metabolic syndrome, by altering the distribution pattern of postprandial energy storage. Following ingestion of two high carbohydrate mixed meals, net muscle glycogen synthesis was reduced by ≈60% in young, lean, insulin-resistant subjects compared with a similar cohort of age–weight–body mass index–activity-matched, insulin-sensitive, control subjects. In contrast, hepatic de novo lipogenesis and hepatic triglyceride synthesis were both increased by >2-fold in the insulin-resistant subjects. These changes were associated with a 60% increase in plasma triglyceride concentrations and an ≈20% reduction in plasma high-density lipoprotein concentrations but no differences in plasma concentrations of TNF-α, IL-6, adiponectin, resistin, retinol binding protein-4, or intraabdominal fat volume. These data demonstrate that insulin resistance in skeletal muscle, due to decreased muscle glycogen synthesis, can promote atherogenic dyslipidemia by changing the pattern of ingested carbohydrate away from skeletal muscle glycogen synthesis into hepatic de novo lipogenesis, resulting in an increase in plasma triglyceride concentrations and a reduction in plasma high-density lipoprotein concentrations. Furthermore, insulin resistance in these subjects was independent of changes in the plasma concentrations of TNF-α, IL-6, high-molecular-weight adiponectin, resistin, retinol binding protein-4, or intraabdominal obesity, suggesting that these factors do not play a primary role in causing insulin resistance in the early stages of the metabolic syndrome.

1 September 2020 in Clinical Nutrition
Verified
Journal Article
Closed access
LHLara Hersberger
Lara Hersberger
LBLaura Bargetzi
Laura Bargetzi
ABAnnika Bargetzi
Annika Bargetzi
PTPascal Tribolet
Pascal Tribolet
RFRebecca Fehr
Rebecca Fehr
PSPhilipp Schuetz
Philipp Schuetz

1 July 2004 in Metabolism
Verified
Journal Article
Closed access
MMM.-A von Mach
M.-A von Mach
RSR Stoeckli
R Stoeckli
SBS Bilz
S Bilz
MKM Kraenzlin
M Kraenzlin
ILI Langer
I Langer
UKU Keller
U Keller